Form 3/A - Initial statement of beneficial ownership of securities: [Amend]
SEC Accession No. 0000950142-25-000188
Filing Date
2025-01-23
Accepted
2025-01-23 18:21:18
Documents
1
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT es250582073_3a-lavelle.html 3/A  
1 OWNERSHIP DOCUMENT es250582073_3a-lavelle.xml 3/A 3362
  Complete submission text file 0000950142-25-000188.txt   4870
Mailing Address C/O MEDICUS PHARMA LTD. 100 KING STREET WEST, SUITE 3400 TORONTO Z4 M5X 1A4
Business Address
Lavelle Frank W (Reporting) CIK: 0001320924 (see all company filings)

Type: 3/A | Act: 34 | File No.: 001-42408 | Film No.: 25551220

Mailing Address 100 KING STREET WEST SUITE 3400 TORONTO A6 M5X 1A4
Business Address 100 KING STREET WEST SUITE 3400 TORONTO A6 M5X 1A4 (732) 300-3046
Medicus Pharma Ltd. (Issuer) CIK: 0001997296 (see all company filings)

EIN.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)